HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Karolina Rembeck Selected Research

Chronic Hepatitis C

6/2014Variants of the inosine triphosphate pyrophosphatase gene are associated with reduced relapse risk following treatment for HCV genotype 2/3.
7/2013Retreatment with peg-interferon and ribavirin in patients with chronic hepatitis C virus genotype 2 or 3 infection with prior relapse.
1/2012Impact of obesity on the bioavailability of peginterferon-α2a and ribavirin and treatment outcome for chronic hepatitis C genotype 2 or 3.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Karolina Rembeck Research Topics

Disease

5Infections
03/2016 - 01/2012
3Chronic Hepatitis C
06/2014 - 01/2012
2Fibrosis (Cirrhosis)
03/2016 - 06/2014
1Liver Diseases (Liver Disease)
01/2015
1Anemia
06/2014
1Thrombocytopenia (Thrombopenia)
06/2014
1Insulin Resistance
09/2012
1Obesity
01/2012
1Virus Diseases (Viral Diseases)
01/2012

Drug/Important Bio-Agent (IBA)

6Ribavirin (Virazole)FDA LinkGeneric
03/2016 - 01/2012
4InterferonsIBA
03/2016 - 01/2012
2Inosine Triphosphate (ITP)IBA
01/2015 - 06/2014
2PyrophosphatasesIBA
01/2015 - 06/2014
1Interferon LambdaIBA
01/2015
1InterleukinsIBA
01/2015
1Phospholipases (Phospholipase)IBA
01/2015
1Inosine TriphosphataseIBA
06/2014
1Antiviral Agents (Antivirals)IBA
09/2012
1RNA (Ribonucleic Acid)IBA
01/2012

Therapy/Procedure

5Therapeutics
03/2016 - 01/2012
1Duration of Therapy
06/2014
1Retreatment
07/2013